Maiwald Magazine

Maiwald Blog

24 Apr 2026 - Maiwald Blog

Analysis of Examination Standards and Case Law for AI and Software-Related Inventions

I am very honored to announce that I have had the opportunity to write a book in Japanese, which has been published. The b...

9 Dec 2025 - Maiwald Blog

New fee schedule for the Unified Patent Court (UPC) from 1 January 2026

The Administrative Committee of the UPC has decided on a comprehensive reform of court fees, which will come into force on 1 January 2026. The adjustment affects almost all fe...

4 Nov 2025 - Maiwald Blog

Why Patent Defense and Military Technologies?

When developing high-tech technologies for use in defense and military applications, you might wonder whether patent protection is necessary. Even though your customer base is...

All articles

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Maiwald in the press

Staff News

2 Mar 2026 - Staff News

Maiwald appoints Dr. Kerstin Wolff as Partner

Maiwald, one of Germany’s leading intellectual property law firms, has appointed Dr. Kerstin Wolff as Partner effective from 1 March 2026. This appointment further strengthe...

29 Jan 2026 - Staff News

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

With retroactive effect from the beginning of the new year, Maiwald, one of Germany's leading intellectual property law firms, has appointed Martina Boidol, Dr. Anja Fux, and ...

11 Nov 2025 - Staff News

Dr Iris Müller and Dr Gabriel Kiefl sworn in as German patent attorneys

We are pleased to announce that our colleagues

All Staff News

Publications

All publications

Awards

25 Mar 2026 - Award

The Legal 500 EMEA 2026: Maiwald recommended in three practice areas

The Legal 500, one of the world’s leading legal directories, has once again recommended Maiwald in the EMEA 2026 edition. Our firm is recognized in the following categories:...

12 Mar 2026 - Award

Maiwald recognized by FOCUS as a Top Medium-Sized Employer 2026

At Maiwald, we continuously strive to create a work environment where all colleagues feel welcome—with a clear focus on feedback, development, and positive collaboration. We...

19 Feb 2026 - Award

Chambers Germany 2026 Rankings

We are proud that Chambers & Partners has once again recognized Maiwald in its Germany 2026 guide — with

All awards

Events

Wed.

29 Apr 2026 |Upcoming|External Events

Maiwald at LSPN North America Spring 2026 in Boston | April 29th-30th

Maiwald will once again participate in one of the most influential IP conferences for the life sciences this year - and is proud to serve as a Gold Sponsor. The annual LSPN Spring conference in Boston is a key meeting point for cutting‑edge insights into IP challenges across the pharmaceutical, biotech...

Sat.

2 May 2026 |Upcoming

Maiwald at INTA Annual Meeting in London | 2-6 May 2026

Maiwald will once again participate in the INTA Annual Meeting, taking place in London from 2–6 May 2026 at ExCeL London. We are pleased that Susanne Ferstl, Rafal Drozdz and Alexander Müller

Tue.

19 May 2026 |Upcoming

Maiwald at C5’s 19th Annual Pharma & Biotech Patent Litigation Forum in Europe

Maiwald will take part in C5’s 19th Annual Forum on Pharma & Biotech Patent Litigation in Europe, which will be held on 19–20 May 2026 at the Radisson Blu Hotel Amsterdam City Center. We are pleased that our colleague Dr. Ulrike Herr will be attending on site.